Periplasmic expression of EGFRvIII extracellular domain as a fusion protein in Escherichia coli NiCo21(DE3)
Open Access
- 1 May 2021
- conference paper
- Published by IOP Publishing in IOP Conference Series: Earth and Environmental Science
- Vol. 762 (1) , 012065
Abstract
Epidermal growth factor receptor variant III is a mutant variant of EGFR that has a deletion on its DNA encoding extracellular ligan-binding domain. EGFRvIII is only found in cancer cells and not in normal cells, make it an ideal target as a biomarker for antibody-based cancer therapy. This study performed the expression and characterization of EGFRvIII extracellular domain conjugated with a blue fluorescent protein (BFP) as a fusion protein in Escherichia coli periplasmic space. Endoxylanase signal peptide was employed to guide the recombinant protein through the membrane. IPTG as inducer was added into expression medium with various concentrations of 0; 0.1; 0.25; 0.5; 1 mM, followed by periplasmic extraction using the hypertonic solution. Total proteins and periplasmic proteins were characterized using SDS-PAGE and slot blot analyses. Extracellular domain of EGFRvIII-BFP fusion protein was detected using confocal fluorescence microscopy. This study showed that the ∼43 kDa target protein was successfully expressed on E. coli NiCo21(DE3) periplasmic space with optimum IPTG concentration of 0.1 mM and and showed a blue fluorescence color under the microscope..Keywords
This publication has 12 references indexed in Scilit:
- Comparison of Gene Expression Between Two Types of Anti-EGFRvIII ScFv Antibodies Having Different Variable Domain Orders in Escherichia coliANNALES BOGORIENSES, 2017
- Construction and Periplasmic Expression of the Anti-EGFRvIII ScFv Antibody Gene in Escherichia coliScientia Pharmaceutica, 2016
- The structure and function of fluorescent proteinsChemical Society Reviews, 2009
- Fluorescent Proteins as Biomarkers and Biosensors: Throwing Color Lights on Molecular and Cellular ProcessesCurrent Protein & Peptide Science, 2008
- The lac repressorComptes Rendus. Biologies, 2005
- Inhibition of the Type III Epidermal Growth Factor Receptor Variant Mutant Receptor by Dominant-Negative EGFR-CD533 Enhances Malignant Glioma Cell RadiosensitivityClinical Cancer Research, 2004
- Secretory and extracellular production of recombinant proteins using Escherichia coliApplied Microbiology and Biotechnology, 2004
- The type III epidermal growth factor receptor mutationAnnals of Oncology, 2001
- The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic targetJournal of NeuroVirology, 1998
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970